Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5499)
All Articles published online
|
Oct 6, 2012 (publication date) through Dec 20, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pharmacology and Therapeutics
ISSN
2150-5349
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | McConnell J, Parvulescu-Codrea S, Behm B, Hill B, Dunkle E, Finke K, Snyder K, Tuskey A, Cox D, Woodward B. Accelerated infliximab infusions for inflammatory bowel disease improve effectiveness. World J Gastrointest Pharmacol Ther 2012; 3(5): 74-82 [PMID: 23515325 DOI: 10.4292/wjgpt.v3.i5.74] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5349/full/v3/i5/74.htm |
| Number | Citing Articles |
| 1 |
Ji Yoon Kim, Shubha Bhat. Safety of Rapid Infliximab Biosimilar Infusions in Patients With Inflammatory Bowel Disease. Annals of Pharmacotherapy 2022; 56(3): 280 doi: 10.1177/10600280211029345
|
| 2 |
Han Geul Byun, Minyoung Jang, Hyun Kyeong Yoo, James Potter, Taek Sang Kwon. Budget Impact Analysis of the Introduction of Subcutaneous Infliximab (CT-P13 SC) for the Treatment of Rheumatoid Arthritis in the United Kingdom. Applied Health Economics and Health Policy 2021; 19(5): 735 doi: 10.1007/s40258-021-00673-1
|
| 3 |
Andrea Michielan, Matteo Martinato, Andrea Favarin, Viviana Zanotto, Roberta Caccaro, Antonino Caruso, Giacomo Carlo Sturniolo, Renata D’Incà. A nurse-led accelerated procedure for infliximab infusion is well tolerated and effective in patients with inflammatory bowel disease. Digestive and Liver Disease 2015; 47(5): 372 doi: 10.1016/j.dld.2015.01.152
|
| 4 |
Daniel M. O'Connell, Joshua Nachreiner, Xin Shu, Erica Terry, Taylor Imburgia, Joshua Vanderloo, Michael R. Lasarev, Monica Bogenschutz. Rapid Infliximab Biosimilar Infusion in Children With Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition 2022; 74(5): 605 doi: 10.1097/MPG.0000000000003402
|
| 5 |
Danning Ma, Wendy Wong, Jeremie Aviado, Cesar Rodriguez, Helen Wu. Safety and Tolerability of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease. American Journal of Gastroenterology 2019; 114(2): 352 doi: 10.1038/s41395-018-0368-1
|
| 6 |
Anna Viola, Giuseppe Costantino, Antonino Carlo Privitera, Fabrizio Bossa, Angelo Lauria, Laurino Grossi, Maria Beatrice Principi, Nicola Della Valle, Maria Cappello. Clinical and economic impact of infliximab one-hour infusion protocol in patients with inflammatory bowel diseases: A multicenter study. World Journal of Gastrointestinal Pharmacology and Therapeutics 2017; 8(2): 131-136 doi: 10.4292/wjgpt.v8.i2.131
|
| 7 |
Suha Abushamma, Ted Walker, Kevin Garza, Ling Chen, Darren Nix, Chien-Huan Chen. Accelerated Infliximab Infusion Safety and Tolerability Is Non-inferior to Standard Infusion Protocol in Inflammatory Bowel Disease Patients: A Randomized Controlled Study. Crohn's & Colitis 360 2023; 5(3) doi: 10.1093/crocol/otad022
|
| 8 |
Anita Afzali, Kristine Ogden, Michael L. Friedman, Jingdong Chao, Anthony Wang. Costs of providing infusion therapy for patients with inflammatory bowel disease in a hospital-based infusion center setting. Journal of Medical Economics 2017; 20(4): 409 doi: 10.1080/13696998.2017.1285779
|
| 9 |
Nicole A Rozette, Christina M Hellauer, Chephra McKee, Turaj Vazifedan, Christos A Gabriel, James E Dice, Nancy U Yokois. Evaluation of Rapid vs Standard Infliximab Infusions in the Pediatric Population. Inflammatory Bowel Diseases 2018; 24(9): 2007 doi: 10.1093/ibd/izy093
|
| 10 |
Blake Rosenthal, Sabreen Aulakh, Perseus V Patel, Jason T Wong, Sabina Ali. Direct transition from rapid-infusion originator to rapid-infusion biosimilar tumor necrosis factor inhibitor in children with inflammatory bowel disease: A case series. American Journal of Health-System Pharmacy 2024; 81(2): 61 doi: 10.1093/ajhp/zxad217
|
| 11 |
Raffaella Franca, Debora Curci, Marianna Lucafò, Giuliana Decorti, Gabriele Stocco. Therapeutic drug monitoring to improve outcome of anti-TNF drugs in pediatric inflammatory bowel disease. Expert Opinion on Drug Metabolism & Toxicology 2019; 15(7): 527 doi: 10.1080/17425255.2019.1630378
|